Frontiers in Immunology,
Journal Year:
2023,
Volume and Issue:
14
Published: Dec. 20, 2023
Background
Myalgic
encephalomyelitis/chronic
fatigue
syndrome
(ME/CFS)
is
a
debilitating
chronic
condition
with
no
identified
diagnostic
biomarkers
to
date.
Its
prevalence
as
high
0.89%
according
metastudies,
quarter
of
patients
bed-
or
home-bound,
which
presents
serious
public
health
challenge.
Investigations
into
the
inflammation–immunity
axis
encouraged
by
links
outbreaks
and
disease
waves.
Recently,
research
our
group
revealed
that
antibodies
beta2-adrenergic
(anti-β2AdR)
muscarinic
acetylcholine
(anti-M4)
receptors
demonstrate
sensitivity
progression
ME/CFS.
The
purpose
this
study
investigate
joint
potential
inflammatome—characterized
interferon
(IFN)-
γ
,
tumor
necrosis
factor
(TNF)-α,
interleukin
(IL)-2,
IL-21,
Il-23,
IL-6,
IL-17A,
Activin-B,
immunome
(IgG1,
IgG2,
IgG3,
IgG4,
IgM,
IgA),
receptor-based
(anti-M3,
anti-M4,
anti-β2AdR)—for
evaluating
ME/CFS
progression,
identify
an
optimal
selection
for
future
validation
in
prospective
clinical
studies.
Methods
A
dataset
was
used
originating
from
188
individuals,
namely,
54
healthy
controls,
30
“mild”
condition,
73
“moderate”
31
“severe”
clinically
assessed
Fukuda/CDC
1994
international
consensus
criteria.
Inflammatome,
immunome,
were
determined
blood
plasma
via
ELISA
multiplex
methods.
Statistical
analysis
done
correlation
analysis,
principal
component
linear
discriminant
random
forest
classification;
inter-group
differences
tested
nonparametric
Kruskal–Wallis
H
test
followed
two-stage
step-up
procedure
Benjamini,
Krieger,
Yekutieli,
Mann–Whitney
U
test.
Results
association
between
inflammatome
markers
broader
stronger
(coupling)
severe
group.
Principal
factoring
separates
components
associated
inflammatome,
receptor
biomarkers.
Random
modeling
demonstrates
excellent
accuracy
over
90%
splitting
healthy/with
groups,
45%
healthy/severity
groups.
Classifiers
highest
are
anti-β2AdR,
IL-2,
IL-6.
Discussion
candidate
controlled
could
be
treatment
individualization.
Thus,
coupling
effects
inflammation
immunity
potentially
beneficial
identification
prognostic
factors
context
mechanism
Trends in Molecular Medicine,
Journal Year:
2024,
Volume and Issue:
30(5), P. 443 - 458
Published: March 4, 2024
Myalgic
encephalomyelitis/chronic
fatigue
syndrome
(ME/CFS)
is
a
debilitating
chronic
illness
often
triggered
by
an
initiating
acute
event,
mainly
viral
infections.
The
transition
from
to
disease
remains
unknown,
but
interest
in
this
phenomenon
has
escalated
since
the
COVID-19
pandemic
and
post-COVID-19
illness,
termed
'long
COVID'
(LC).
Both
ME/CFS
LC
share
many
clinical
similarities.
Here,
we
present
recent
findings
research
focussing
on
proposed
pathologies
shared
with
LC.
Understanding
these
how
they
influence
each
other
key
developing
effective
therapeutics
diagnostic
tests.
Given
that
typically
longer
duration
compared
LC,
symptoms
evolving
over
time,
may
provide
insights
into
future
progression
of
Biochemical Society Transactions,
Journal Year:
2024,
Volume and Issue:
52(2), P. 733 - 745
Published: March 13, 2024
In
the
past
two
decades,
immunometabolism
has
emerged
as
a
crucial
field,
unraveling
intricate
molecular
connections
between
cellular
metabolism
and
immune
function
across
various
cell
types,
tissues,
diseases.
This
review
explores
insights
gained
from
studies
using
emerging
technology,
Raman
micro-spectroscopy,
to
investigate
immunometabolism.
micro-spectroscopy
provides
an
exciting
opportunity
directly
study
at
single
level
where
it
can
be
combined
with
other
Raman-based
technologies
platforms
such
RNA
sequencing.
The
showcases
applications
of
system
including
identification,
activation,
autoimmune
disease
diagnosis,
offering
rapid,
label-free,
minimally
invasive
analytical
approach.
spotlights
three
promising
technologies,
Raman-activated
sorting,
stable
isotope
probing,
imaging.
synergy
machine
learning
is
poised
enhance
understanding
complex
phenotypes,
enabling
biomarker
discovery
comprehensive
investigations
in
encourages
further
exploration
these
evolving
rapidly
advancing
field
Advanced Science,
Journal Year:
2023,
Volume and Issue:
10(30)
Published: Aug. 31, 2023
Abstract
Myalgic
encephalomyelitis/chronic
fatigue
syndrome
(ME/CFS)
is
characterized
by
debilitating
that
profoundly
impacts
patients'
lives.
Diagnosis
of
ME/CFS
remains
challenging,
with
most
patients
relying
on
self‐report,
questionnaires,
and
subjective
measures
to
receive
a
diagnosis,
many
never
receiving
clear
diagnosis
at
all.
In
this
study,
single‐cell
Raman
platform
artificial
intelligence
are
utilized
analyze
blood
cells
from
98
human
subjects,
including
61
varying
disease
severity
37
healthy
controls.
These
results
demonstrate
profiles
can
distinguish
between
individuals,
controls,
high
accuracy
(91%),
further
differentiate
mild,
moderate,
severe
(84%).
Additionally,
specific
peaks
correlate
phenotypes
have
the
potential
provide
insights
into
biological
changes
support
development
new
therapeutics
identified.
This
study
presents
promising
approach
for
aiding
in
management
be
extended
other
unexplained
chronic
diseases
such
as
long
COVID
post‐treatment
Lyme
syndrome,
which
share
same
symptoms
ME/CFS.
Journal of Translational Medicine,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: Jan. 14, 2025
Abstract
Myalgic
Encephalomyelitis/Chronic
Fatigue
Syndrome
(ME/CFS)
is
a
complex
and
multifaceted
disorder
that
defies
simplistic
characterisation.
Traditional
approaches
to
diagnosing
treating
ME/CFS
have
often
fallen
short
due
the
condition’s
heterogeneity
lack
of
validated
biomarkers.
The
growing
field
precision
medicine
offers
promising
approach
which
focuses
on
genetic
molecular
underpinnings
individual
patients.
In
this
review,
we
explore
how
machine
learning
multi-omics
(genomics,
transcriptomics,
proteomics,
metabolomics)
can
transform
in
research
healthcare.
We
provide
an
overview
concepts
for
analysing
large-scale
biological
data,
highlight
key
advancements
biomarker
discovery,
data
quality
integration
strategies,
while
reflecting
case
study
examples.
also
several
priorities,
including
critical
need
applying
robust
computational
tools
collaborative
data-sharing
initiatives
endeavour
unravel
intricacies
ME/CFS.
Frontiers in Neuroscience,
Journal Year:
2025,
Volume and Issue:
19
Published: March 10, 2025
Myalgic
encephalomyelitis/chronic
fatigue
syndrome
(ME/CFS),
Gulf
War
Syndrome
(GWS),
and
Fibromyalgia
(FM)
are
complex,
chronic
illnesses
with
overlapping
clinical
features.
Symptoms
that
reported
across
these
conditions
include
post-exertional
malaise
(PEM),
fatigue,
pain,
yet
the
etiology
of
remains
largely
unknown.
Diagnosis
is
challenging
in
patients
as
definitive
biomarkers
lacking;
required
to
meet
criteria
often
undergo
lengthy
testing
exclude
other
conditions,
a
process
prolonged,
costly,
burdensome
for
patients.
The
identification
reliable
validated
could
facilitate
earlier
more
accurate
diagnosis
drive
development
targeted
pharmacological
therapies
might
address
underlying
pathophysiology
diseases.
Major
driving
forces
biomarker
advancing
fields
metabolomics
proteomics
allow
comprehensive
characterization
metabolites
proteins
biological
specimens.
Recent
technological
developments
areas
enable
high-throughput
analysis
thousands
from
variety
samples
model
systems,
provides
powerful
approach
unraveling
metabolic
phenotypes
associated
complex
Emerging
evidence
suggests
ME/CFS,
GWS,
FM
all
characterized
by
disturbances
pathways,
particularly
those
related
energy
production,
lipid
metabolism,
oxidative
stress.
Altered
levels
key
pathways
have
been
studies
highlighting
potential
common
biochemical
abnormalities.
precise
mechanisms
altered
remain
be
elucidated;
however,
elevated
stress
observed
may
contribute
symptoms
offer
target
therapeutic
intervention.
Investigating
mechanisms,
their
role
disease
process,
provide
insights
into
pathogenesis
reveal
novel
treatment
targets.
As
such,
metabolomic
proteomic
analyses
crucial
understanding
in-order
identify
both
common,
unique,
alterations
serve
diagnostic
markers
or
Annals of the New York Academy of Sciences,
Journal Year:
2024,
Volume and Issue:
1535(1), P. 31 - 41
Published: April 9, 2024
In
2023,
the
Keystone
Symposia
held
first
international
scientific
conference
convening
research
leaders
investigating
pathology
of
post-acute
sequelae
COVID-19
(PASC)
or
Long
COVID,
a
growing
and
urgent
public
health
priority.
this
report,
we
present
insights
from
talks
workshops
presented
during
meeting
highlight
key
themes
regarding
what
researchers
have
discovered
underlying
biology
PASC
directions
toward
future
treatment.
Several
emerged
in
biology,
with
inflammation
other
immune
alterations
being
most
common
focus,
potentially
related
to
viral
persistence,
latent
virus
reactivation,
and/or
tissue
damage
dysfunction,
especially
endothelium,
nervous
system,
mitochondria.
order
develop
safe
effective
treatments
for
people
PASC,
critical
next
steps
should
focus
on
replication
major
findings
potential
mechanisms,
disentangling
pathogenic
mechanisms
downstream
effects,
development
cellular
animal
models,
mechanism-focused
randomized,
placebo-controlled
trials,
closer
collaboration
between
lived
experience,
scientists,
stakeholders.
Ultimately,
by
learning
post-infectious
syndromes,
knowledge
gained
may
help
not
only
those
PASC/Long
but
also
syndromes.
Theranostics,
Journal Year:
2024,
Volume and Issue:
14(17), P. 6818 - 6830
Published: Jan. 1, 2024
Dynamic
real-time
detection
of
dendritic
cell
(DC)
maturation
is
pivotal
for
accurately
predicting
immune
system
activation,
assessing
vaccine
efficacy,
and
determining
the
effectiveness
immunotherapy.
The
heterogeneity
cells
underscores
significance
status
each
individual
cell,
while
achieving
monitoring
DC
at
single-cell
level
poses
significant
challenges.
Surface-enhanced
Raman
spectroscopy
(SERS)
holds
great
potential
providing
specific
fingerprinting
information
DCs
to
detect
biochemical
alterations
evaluate
their
status.
Communications Medicine,
Journal Year:
2024,
Volume and Issue:
4(1)
Published: Nov. 26, 2024
Diagnosing
complex
illnesses
like
Myalgic
Encephalomyelitis/Chronic
Fatigue
Syndrome
(ME/CFS)
is
complicated
due
to
the
diverse
symptomology
and
presence
of
comorbid
conditions.
ME/CFS
patients
often
present
with
multiple
health
issues,
therefore,
incorporating
comorbidities
into
research
can
provide
a
more
accurate
understanding
condition's
symptomatology
severity,
better
reflect
real-life
patient
experiences.
We
performed
association
studies
machine
learning
on
1194
individuals
blood
plasma
nuclear
magnetic
resonance
(NMR)
metabolomics
profiles,
seven
exclusive
cohorts:
hypertension
(n
=
13,559),
depression
2522),
asthma
6406),
irritable
bowel
syndrome
859),
hay
fever
3025),
hypothyroidism
1226),
migraine
1551)
non-diseased
control
group
53,009).
lipoprotein
perspective
pathophysiology,
highlighting
gender-specific
differences
identifying
overlapping
associations
conditions,
specifically
surface
lipids,
ketone
bodies
from
168
significant
individual
biomarker
associations.
Additionally,
we
searched
for,
trained,
optimised
algorithm,
resulting
in
predictive
model
using
19
baseline
characteristics
nine
NMR
biomarkers
which
could
identify
an
AUC
0.83
recall
0.70.
A
multi-variable
score
was
subsequently
derived
same
28
features,
exhibited
~2.5
times
greater
than
top
biomarker.
This
study
provides
end-to-end
analytical
workflow
that
explores
potential
clinical
utility
scores
may
have
for
other
difficult
diagnose
illness
severe
fatigue
without
known
cause.
Further
symptoms
overlap
medical
problems
making
diagnosis
difficult.
wanted
find
way
easily
people
this
condition,
so
used
data
UK
Biobank
compare
who
had
problems.
developed
mathematical
calculation,
basic
factors
markers,
classify
non-ME/CFS
correctly
83%
time,
recognise
condition
70%
time.
lead
serve
as
example
diseases
lacking
definite
laboratory
testing.
Huang
et
al.
train
optimize
predict
cases
Biobank.
works
heterogenous
condition.
ACS Chemical Neuroscience,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 20, 2024
Myalgic
encephalomyelitis/chronic
fatigue
syndrome
(ME/CFS)
is
a
chronic,
complex
illness
characterized
by
severe
and
often
disabling
physical
mental
fatigue.
So
far,
scientists
have
not
been
able
to
fully
pinpoint
the
biological
cause
of
yet
it
affects
millions
people
worldwide.
To
gain
better
understanding
ME/CFS,
we
compared
metabolic
networks
in
plasma
38
ME/CFS
patients
those
24
healthy
control
participants.
This
involved
an
untargeted
metabolomics
approach
addition
measurement
targeted
substances
including
tryptophan
its
metabolites,
as
well
tyrosine,
phenylalanine,
B
vitamins,
hypoxanthine
using
liquid
chromatography
coupled
mass
spectrometry.
We
observed
significant
alterations
several
pathways,
vitamin
B3,
arginine-proline,
aspartate-asparagine
analysis.
The
analysis
revealed
changes
levels
3-hydroxyanthranilic
acid,
3-hydroxykynurenine,
hypoxanthine,
phenylalanine
group.
These
findings
suggest
potential
immune
system
response
oxidative
stress
patients.